| Nanoliposomal minocycline for ocular drug delivery JM Kaiser, H Imai, JK Haakenson, RM Brucklacher, TE Fox, ... Nanomedicine: Nanotechnology, Biology and Medicine 9 (1), 130-140, 2013 | 55 | 2013 |
| C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia LK Ryland, UA Doshi, SS Shanmugavelandy, TE Fox, C Aliaga, K Broeg, ... PLoS One 8 (12), e84648, 2013 | 50 | 2013 |
| Diversity in the cow ultralong CDR H3 antibody repertoire JK Haakenson, R Huang, VV Smider Frontiers in immunology 9, 380945, 2018 | 43 | 2018 |
| The unusual genetics and biochemistry of bovine immunoglobulins RL Stanfield, J Haakenson, TC Deiss, MF Criscitiello, IA Wilson, ... Advances in immunology 137, 135-164, 2018 | 39 | 2018 |
| PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate BM Barth, SS Shanmugavelandy, JM Kaiser, C McGovern, EI Altınoğlu, ... ACS nano 7 (3), 2132-2144, 2013 | 39 | 2013 |
| Ceramide kinase regulates TNFα-stimulated NADPH oxidase activity and eicosanoid biosynthesis in neuroblastoma cells BM Barth, SJ Gustafson, JL Hankins, JM Kaiser, JK Haakenson, M Kester, ... Cellular signalling 24 (6), 1126-1133, 2012 | 39 | 2012 |
| Lysosomal degradation of CD44 mediates ceramide nanoliposome-induced anoikis and diminished extravasation in metastatic carcinoma cells JK Haakenson, AV Khokhlatchev, YJ Choi, SS Linton, P Zhang, PM Zaki, ... Journal of Biological Chemistry 290 (13), 8632-8643, 2015 | 20 | 2015 |
| A broad role for cysteines in bovine antibody diversity JK Haakenson, TC Deiss, GF Warner, W Mwangi, MF Criscitiello, ... Immunohorizons 3 (10), 478-487, 2019 | 18 | 2019 |
| The therapeutic potential of nanoscale sphingolipid technologies JL Hankins, UA Doshi, JK Haakenson, MM Young, BM Barth, M Kester Sphingolipids: Basic Science and Drug Development, 197-210, 2013 | 12 | 2013 |
| The ATF/CREB family of transcription factors in breast cancer JK Haakenson, M Kester, DX Liu Targeting new pathways and cell death in breast cancer, 2012 | 10 | 2012 |
| Evolution of immunogenetic components encoding ultralong CDR H3 JA Ott, C Mitchell, M Sheppard, TC Deiss, JMC Horton, JK Haakenson, ... Immunogenetics 75 (4), 323-339, 2023 | 2 | 2023 |
| Immunization of cows with HIV envelope trimers generates broadly neutralizing antibodies to the V2-apex from the ultralong CDRH3 repertoire P Altman, G Ozorowski, R Stanfield, J Haakenson, M Appel, M Parren, ... bioRxiv, 2024.02. 13.580058, 2024 | 1 | 2024 |
| Evolution of surrogate light chain in tetrapods and the relationship between lengths of CDR H3 and VpreB tails JA Ott, JK Haakenson, AR Kelly, C Christian, MF Criscitiello, VV Smider Frontiers in Immunology 13, 1001134, 2022 | 1 | 2022 |
| Evolution of immunogenetic components used to form ultralong VH CDR3 antibodies in Bovidae CD Mitchell, AJ Marchand, K Head, JK Haakenson, A Kelley, TC Deiss, ... The Journal of Immunology 206 (1_Supplement), 19.08-19.08, 2021 | | 2021 |
| The Role of Ceramide in Metastatic Processes in Breast Cancer JK Haakenson | | 2015 |
| Chemotherapy and Sphingolipid Metabolism UA Doshi, JK Haakenson, SS Linton, K Kelly, M Kester Bioactive Sphingolipids in Cancer Biology and Therapy, 401-436, 2015 | | 2015 |
| Cloning bovine immunoglobulin VH and VL genes from single B cells. GF Warner, JK Haakenson, VV Smider | | |
| PhotoImmunoNanoTherapy Reveals an Anticancer Role for Sphingosine Kinase EI Altnoğlu, JK Haakenson, JA Hengst, EL Gilius, SA Knupp | | |
